Literature DB >> 19178527

Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS).

Evan Atlantis1, Sean A Martin, Matthew T Haren, Peter D O'Loughlin, Anne W Taylor, Ravinder Anand-Ivell, Richard Ivell, Gary A Wittert.   

Abstract

OBJECTIVE: Plasma androgen levels are inversely associated with health in men, the age-related decline of which may result from factors other than ageing per se. This study aimed to determine the effects of demographic, physical and lifestyle factors on age-related androgen status in men.
DESIGN: An observational survey of a regionally representative male population residing in the North West regions of Adelaide, Australia. PARTICIPANTS: Study sample includes 1195 men aged 35-81 years with a response rate of 45.1%. MEASUREMENTS: Plasma levels of total testosterone (TT), bioavailable testosterone (BT), SHBG, insulin-like peptide 3 (INSL3), and gonadotrophins were measured along with an extensive list of demographic, physical and lifestyle factors including body composition, muscle strength and biomarkers of chronic diseases, physical activity, nutrition and smoking behaviour.
RESULTS: Low TT was mostly associated with high abdominal fat and triglycerides and low muscle strength rather than ageing per se. Low BT was associated with increased age followed by high whole body fat percentage. BT and TT levels were higher in unmarried men and smokers. SHBG levels increased with age, but were also inversely associated with insulin and triglycerides. The Leydig cell specific factor INSL3 was the strongest biomarker associated with both TT and BT.
CONCLUSIONS: Factors associated with low androgen status variably include high body fat percentage, low muscle strength and biomarkers of the metabolic syndrome. Reducing exposure to factors that adversely affect androgen status may improve the general health of ageing men by mechanisms yet to be defined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178527     DOI: 10.1111/j.1365-2265.2008.03463.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

Review 1.  Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.

Authors:  Alberto Ferlin; Luca De Toni; Marco Sandri; Carlo Foresta
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

3.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

4.  The influence of age on bioavailable and free testosterone is independent of body mass index and glucose levels.

Authors:  Graziele Halmenschlager; Ernani Luis Rhoden; Charles Edison Riedner
Journal:  World J Urol       Date:  2011-07-08       Impact factor: 4.226

5.  Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency.

Authors:  Carolyn A Allan; Roger E Peverill; Boyd Jg Strauss; Elise A Forbes; Robert I McLachlan
Journal:  Asian J Androl       Date:  2011-04-11       Impact factor: 3.285

Review 6.  Endocrinology of the aging male.

Authors:  Andre B Araujo; Gary A Wittert
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

Review 7.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

8.  Predictive value of serum testosterone for type 2 diabetes risk assessment in men.

Authors:  Evan Atlantis; Paul Fahey; Sean Martin; Peter O'Loughlin; Anne W Taylor; Robert J Adams; Zumin Shi; Gary Wittert
Journal:  BMC Endocr Disord       Date:  2016-05-27       Impact factor: 2.763

9.  A cross-sectional study of the association of age, race and ethnicity, and body mass index with sex steroid hormone marker profiles among men in the National Health and Nutrition Examination Survey (NHANES III).

Authors:  Jamie Ritchey; Wilfried Karmaus; Tara Sabo-Attwood; Susan E Steck; Hongmei Zhang
Journal:  BMJ Open       Date:  2012-10-06       Impact factor: 2.692

10.  Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Authors:  Evan Atlantis; Paul Fahey; Belinda Cochrane; Gary Wittert; Sheree Smith
Journal:  BMJ Open       Date:  2013-08-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.